Europe
DiaSorin, MeMed Ink Italian Distribution Deal for Test to Differentiate Bacterial, Viral Infection
The partnership enables DiaSorin to distribute the MeMed BV test on the Liaison XL and XS as well as on the MeMed Key point-of-need system.
In Brief This Week: SALSA Act, Thermo Fisher Scientific, Eurobio, Tianlong, Enzo Biochem, More
News items for the week of May 22, 2023.
Labcorp Licenses Proteomedix Prostate Cancer Test
Labcorp obtained exclusive US rights to the test, which is intended for assessing risk of clinically significant prostate cancer in men with elevated PSA.
Freenome Acquires Cancer Dx Firm Oncimmune
Oncimmune offers its CE-marked EarlyCDT Lung blood test, an autoantibody platform, and a research and development pipeline of more than seven cancer detection signatures.
Top Five Articles on 360Dx Last Week: LabCorp Ordered to Pay Ravgen Another $100M; More
Last week, readers were most interested in a story on Labcorp being ordered to pay an additional $100 million to Ravgen in a patent lawsuit.